NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - November 22, 2019 Category: Cancer & Oncology Authors: Mingsheng Chen Yingying Cheng Zhihai Yuan Fenglu Wang Lei Yang Haikang Zhao Source Type: research